1. Four rearing temperature regimes (15, 20, 25, 30 °C) and three feeding schedules (ad libitum, restricting to the ad libitum intake of the 12th week and feeding 70% of this rate) were carried out with layer replacement pullets to 170 d of age. From this age, during lay, birds were kept at either 21 °C or on a 24‐h cycle of 21 for 18 h and 28 °C for the 6 h before lights out. Both a white and a brown egg‐laying strain were used.
2. Body weight at 169 d of age varied from, on average, 1409 g (15 °C, ad libitum) to 943 g (30 °C, 70% schedule) for the white strain and 1947 to 1250 g for the same treatments respectively for the brown strain. Sexual maturity was considerably delayed by the 70% feeding schedule, only slightly by rearing at 30 °C.
3. Rearing at 30 °C tended to depress subsequent egg output. The 70% feeding schedule at least maintained egg output compared with birds fed ad libitum in rearing.
4. There was a highly significant effect of temperature treatment during lay on food intake. The reduction in food intake due to the 21–28 °C cycle, however, appeared small. 相似文献
OBJECTIVE: To determine hepatotoxicity of stanozolol in cats and to identify clinicopathologic and histopathologic abnormalities in cats with stanozolol-induced hepatotoxicosis. DESIGN: Clinical trial and case series. ANIMALS: 12 healthy cats, 6 cats with chronic renal failure, and 3 cats with gingivitis and stomatitis. PROCEDURES: Healthy cats and cats with renal failure were treated with stanozolol (25 mg, i.m., on the first day, then 2 mg, p.o., q 12 h) for 4 weeks. Cats with gingivitis were treated with stanozolol at a dosage of 1 mg, p.o., every 24 hours. RESULTS: Most healthy cats and cats with renal failure developed marked inappetence, groomed less, and were less active within 7 to 10 days after initiation of stanozolol administration. Serum alanine transaminase (ALT) activity was significantly increased in 14 of 18 cats after stanozolol administration, but serum alkaline phosphatase activity was mildly increased in only 3. Four cats with serum ALT activity > 1,000 U/L after only 2 weeks of stanozolol administration had coagulopathies; administration of vitamin K resolved the coagulopathy in 3 of the 4 within 48 hours. All 18 cats survived, and hepatic enzyme activities were normal in all cats tested more than 4 weeks after stanozolol administration was discontinued. Two of the 3 cats with gingivitis developed evidence of severe hepatic failure 2 to 3 months after initiation of stanozolol treatment; both cats developed coagulopathies. Histologic evaluation of hepatic biopsy specimens from 5 cats revealed diffuse hepatic lipidosis and cholestasis without evidence of hepatocellular necrosis. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that stanozolol is hepatotoxic in cats. 相似文献